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ABSTRACT 
BACKGROUND AND OBJECTIVES 
Spinal anaesthesia is one of the most commonly used regional 
technique in anaesthesia. It is economical,safe and cost 
effective.Preferred technique of choice in obstetric patients. 
The objective of the present study is to compare the incidence of 
Postdural puncture headache in obstetric patients following spinal 
anaesthesia using 25 gauge Whitacre and 25 gauge Quincke spinal 
needles. 
METHODOLOGY 
This one year randomized control study was conducted in the 
Department of Anaesthesiology, Institute of Social Obstetrics, 
Government Kasthurba Gandhi Hospital For Women And Child, 
Triplicane, Chennai-5, during the year 2013-2014. Obstetric patients 
posted for elective LSCS were included in the study. The Institutional 
Ethical Committee clearance and written informed consent from the 
patients obtained. Incidence of PDPH following spinal anaesthesia 
,number of attempts for a successful blockade and failed blocks are 
assessed. 
 RESULTS 
In this study, study groups contain subjects  with same 
demographic characters like age, height and weight. The occurance of 
PDPH was meaningfully less(3.3%) when pencil  point whitacre is used 
compared to cutting quincke babcocks needle (10.8  %). 
It was mild in 6%, moderate in 12%, severe in 6% of patients in 
whitacre group. In quincke group it was mild in 29%, moderate in 35%, 
severe in 5% 
INTERPRETATION AND CONCLUSION 
There is a real advantage of using pencil point whitacre needle in 
comparison to cutting bevelled quincke needle. 
KEYWORDS 
Post dural puncture headache , failed spinal, subarachnoid 
block,quincke needle, whitacre needle                
  
INTRODUCTION	
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INTRODUCTION 
Subarachnoid block is the widely used technique by the 
anaesthesiologist worldwide. Spinal anaesthesia dates back to late 1800 
with the work of Wynter,Quincke and Corning. However Dr.Karl August 
Bier is given the credit for introducing spinal anaesthesia into clinical 
practice in 1898. 
The main advantage of SAB is due to its 
· simplicity. 
· ease of performance. 
· requirement of minimal apparatus. 
· minimal effect on blood biochemistry 
· conscious patient maintaining airway 
· good immediate postoperative pain relief 
· blunts stress response to surgery 
· decreased thromboembolic events 
Though popular still,subarachnoid block is not without 
complications. One of the common complication is Postdural puncture 
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headache. Bier gained first-hand experience of the disabling headache 
related to dural puncture. He correctly summarized that the headache was 
related to excessive loss of CSF. 
PDPH causes considerable morbidity, with symptoms lasting for 
several  days,  at  times  severe  enough  to  immobilize  the  patients.  It  
increases the duration of   hospital  stay.  In addition to this,  it  warrents  a  
battery of investigations  to rule out different  causes of headache. This 
PDPH is more distressing to the mother who is supposed to take care of 
the newborn baby. 
There are lot of studies done regarding the  measures for the 
reduction of PDPH. It is said that with the help of fine gauge spinal 
needle and needle tip modification, we can reduce the incidence to a 
greater extend. 
The 25 gauge Quincke babcock with medium cutting bevel is the 
most popular and widely used spinal needle. A balance has to be done 
between the incidence of PDPH and the technical difficulties with the use 
of fine gauge spinal needles. 
My study is to compare the incidence and the severity of PDPH in 
obstetric patients using 25 gauge cutting tip Quincke spinal needle and 25 
gauge pencil tip Whitacre spinal needle 
AIMS	AND	
OBJECTIVES	
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AIM OF THE STUDY 
 
The aim of the study is to compare the incidence of PDPH,using 25 
gauge Quincke spinal needle and 25 gauge Whitacre spinal needle in 
obstetric patients. 
PRIMARY AIM   
Incidence and Severity of PDPH. 
SECONDARY AIM 
Number of attempts for successful blockade. 
Number of failed blocks. 
 
  
ANATOMY	OF	
SUBARACHNOID	
SPACE	
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ANATOMY OF THE SUBARACHNOID SPACE 
The key to successful subarachnoid blockade is combining 
appropriate technique with a three dimensional picture and appreciation 
of vertebral anatomy. 
VERTEBRAL COLUMN 
It consists of 33 vertebra. 
· 7 cervical 
· 12 thoracic 
· 5 lumbar 
· 5 fused sacral 
· 4 fused coccygeal bone. 
VERTEBRAL CANAL 
The bony canal is formed by the body of vertebra anteriorly, 
posteriorly by two pedicles and the laminae connecting the pedicles. This 
canal protects the spinal cord and contains spinal cord with surrounding 
spinal meninges, spinal nerves and cerebrospinal fluid. The lamina gives 
rise to the transverse process laterally and the spinous process posteriorly. 
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Figure 1 : Lumbar Vertebra 
Figure 2 : Vertebra and spinal cord 
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Figure 3 : Vertebral column 
CURVES OF SPINE 
There are 4 curves. They are 
i. Cervical curve-convex anteriorly. 
ii. Dorsal curve-concex posteriorly. 
iii. Lumbar curve-convex anteriorly. 
iv. Sacrococcygeal-convex posteriorly. 
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These curves are important when the patient lies supine and these 
can be modified by posture and the flexibility of the spine. 
The highest point is at the level of L3 and the lowest point is at T5 
level. 
In Pregnancy, the lumbar curve is exaggerated  
STRUCTURES PIERCED  
The following structures are pierced when performing a SAB 
· skin and subcutaneous tissue 
· supraspinous ligaments 
· interspinous ligament 
· ligamentum flavum 
· areolar tissue or epidural space 
· duramater 
ANATOMY OF LIGAMENTS 
(i) SUPRASPINOUS LIGAMENT 
It is a strong, thick, fibrous band extending from the spine of 
seventh cervical vertebra to the sacral spine. 
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(ii) INTERSPINOUS LIGAMENTS 
It is a thin, fibrous structure connecting adjacent spines. These 
fibres meet supraspinous ligament posteriorly and blend with ligamentum 
flavum anteriorly. 
(iii) LIGAMENTUM FLAVUM 
It is a yellow elastic tissue, perpendicular fibres running from the 
anterior inferior surface of upper lamina to the antero superior surface of 
the lower lamina. It exist as right and left half in each intervertebral 
space, with the halves fusing in midline. 
TOPOGRAPHIC LINE OF TUFFIERS 
                  A line joining the highest point of the iliac crest passes over 
the spine of the fourth lumbar vertebra in the upright position or between 
L4-L5 interspace in the lateral position is called Tuffiers line.  
 
 
Figure 4 : Structures pierced 
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Figure 5 : Intrathecal Space 
Figure 6 : Coverings of Spinal Cord 
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SPINAL CORD 
The spinal cord is surrounded by three protective membranes 
duramater, piamater, arachnoid mater, which are continuous with cranial 
meninges. It is continuous cephalad with the brain stem through the 
foramen magnam and terminates distally in the conus medullaris. 
Differential growth rates between the bony vertebral canal and CNS 
causes this distal termination to vary from L3 in infants to lower border 
of L1 in adults. 
SUBARACHNOID SPACE 
It is the space between piamater and arachnoidmater. It has CSF, 
Spinal nerves, trabecular network between the membranes, blood vessels 
that supply the spinal cord, lateral extension of piamater, dentate 
ligaments providing lateral support from the spinal cord to the duramater. 
The subarachnoid space ends at the level of S2. 
SPINAL MEMBRANES 
Innermost layer is the piamater, which is highly vascular and 
closely invest the spinal cord. 
Middle layer is arachnoid mater which is non-vascular, delicate 
membrane closely attached to the outermost layer-the duramater. 
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Duramater is outermost, randomly organized fibroelastic 
membrane, which extends from foramen magnum to S2,where the 
filumterminale  blends with the periostium in coccy 
CEREBROSPINAL FLUID 
It is a complex solution produced by plasma ultra filteration in 
choroid plexus within cerebral ventricles. 
                     Volume of CSF-100 to 160ml. 
                     Rate of production-20 to 25ml/hr. 
Absorbed in the arachnoid villi in the superior saggital sinus and/or 
into lymphatics via perineural sheaths of cranial and spinal nerves. 
CSF contains 
Proteins  : 15-45mg/dl 
Glucose   : 50-80mg/dl 
Non protein  : 20-30mg/dl 
Chloride  : 120-130meq/l 
Sodium  : 140-150meq/l 
Bicarbonate  : 25-30meq/l 
PH    : 7.4-7.6 
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ARTERIAL BLOOD SUPPLY 
Anterior  two  third  of  spinal  cord  is  supplied  by  anterior  spinal  
artery, formed at foramen magnum by a branch from terminal portion of 
vertebral artery. 
Posterior one third is supplied by two pairs of posterior spinal 
artery derived from vertebral artery directly or from posterior inferior 
cerebellar artery. 
One of the anterior radicular branches arising from segmental 
artery is considerably large and called Artery Of Adamkiewics. It 
provides  rich  reinforcement  to  the  flow  of  anterior  spinal  artery  in  its  
lower distribution. It arises from the descending aorta at the lower 
thoracic or upper lumbar level usually on the left side 
VENOUS DRAINAGE 
Veins are situated in the piamater. They are six in numbers and 
form longitudinal plexiform channels after draining the parenchyma of 
the cord. They emerge chiefly from the median fissure of the cord and are 
larger in lumbar region. In this plexus, there are 
i. two median longitudinal veins,one anterior in the anterior 
fissure and the other in the posterior sulcus of  the cord. 
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ii. four lateral longitudinal veins,one pair runs dorsal to the 
attachment of nerve roots and the other ventral to the nerve 
root. 
These veins communicate with the internal vertebral plexus, from 
which blood drains into intervertebral veins. It then drains into segmental 
veins and external vertebral plexus. 
Near the base of the skull, the longitudinal channels surrounding 
the cord units and form two or three small trunks, which communicate 
with internal vertebral plexus, then intervertebral veins and the segmental 
veins, then with cranial venous sinuses, ending in inferior petrosal 
sinuses.                    
VEINS OF THE VERTEBRAL COLUMN: 
                The plexuses and the veins of the vertebral system are 
· External plexus 
· Internal plexus 
· Basivertebral  veins 
· Intervertebral veins 
· Spinal cord veins   
PHYSIOLOGY	OF	
SPINAL	
ANAESTHESIA	
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PHYSIOLOGY OF SPINAL ANAESTHESIA 
The principle site of action of SAB is believed to be the nerve root. 
Local anaesthetic agent injected into the subarachnoid space, baths the 
nerve roots  floating in CSF. They act by blocking the neural transmission 
in the posterior nerve roor fibres and interrupts somatic and visceral 
sensation. They block the anterior nerve root fibre also and prevent 
efferent motor and autonomic outflow. 
SOMATIC BLOCKADE 
SAB provides excellent muscle relaxation by blocking afferent 
transmission of painful stimuli and efferent impulse responsible for 
skeletal muscle tone. Sensory blockade interrupts both somatic and 
visceral  painful  stimuli.  The size and character  of  the fibre type and the 
fact that the concentration of local anaesthetic agent decreases with 
increasing distance from the level of injection, explains the phenomenon 
of Differential Blockade. 
Differential Blockade results in sympathetic blocked(judged by 
temperature sensitivity),that may be two segments or more cephalad than 
the sensory block (pain, light touch),which, in turn, is usually several 
segments more cephalad than motor blockade. 
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AUTONOMIC BLOCKADE 
Interruption of efferent autonomic transmission at the spinal nerve 
roots during neuraxial block produces sympathetic blockade. The 
physiological response of neuraxial blockade results from decreased 
sympathetic tone and/or unopposed parasympathetic tone. 
CARDIOVASCULAR  MANIFESTATIONS:(CVS) 
Neuraxial blockade produces decrease in blood pressure, 
accompanied by decrease in heart rate.T5-L1 sympathetic fibres 
determine the vasomotor tone. Blocking these nerves causes vasodilation 
of venous capacitance vessels and pooling of blood in the viscera and 
lower extremity, thereby decreasing effective circulating blood volume 
and venous return to the heart. 
Arterial vasodilation decreases systemic vascular resistance. The 
effect of arterial vasodilation may be minimized by compensatory 
vasoconstriction above the level of block. A high sympathetic block not 
only prevents compensatory vasoconstriction, but also block the 
sympathetic cardio acceleratory fibres that arise at T1-T4.Profound 
hypotension can result from arterial vasodilation, venous pooling and 
bradycaria. Unopposed vagal tone explains the sudden cardiac arrest seen 
with spinal anaesthesia. 
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PULMONARY MANIFESTATIONS 
Alteration in Pulmonary physiology is minimal with neuraxial 
blockade because the Phrenic  nerve is innervated by fibres  from C3-C5. 
Tidal volume is unchanged. There can be a mild decrease in Vital 
capacity, which results from a loss of the abdominal muscle contribution 
to forced expiration. Patients with severe respiratory disease depent on 
accessory muscle of respiration to actively inspire and expire. High 
neuraxial blockade in these patients may impair effective coughing  and 
clearing of secretions. Hence neuraxial blocks should be used with 
caution in patients with respiratory reserve. 
GASTROINTESTINAL MANIFESTATIONS 
Sympathetic outflow originates at T5-S1. Neuraxial block-induced 
sympathectomy allows vagal tone predominance and results in a small 
contracted gut with active peristalsis. This improves operative conditions. 
Postoperative epidural analgesia hastens the return of 
gastrointestinal function after open abdominal procedures. 
Hepatic will decrease with reduction in mean arterial pressure. 
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URINARY TRACT MANIFESTATIONS 
There is little effect on renal function as the autoregulation 
maintains renal blood flow. Neuraxial blockade at the lumbar and sacral 
segments blocks both sympathetic and parasympathetic control of bladder 
function. Loss of autonomic bladder control results in urinary retention 
until the block wears off. 
METABOLIC AND ENDOCRINE MANIFESTATIONS 
In addition to local inflammatory response produced by surgical 
trauma, systemic neuroendocrine response occurs via activation of 
somatic and visceral afferent nerve fibres. This response includes 
increased concentration of adrenocorticotropic harmone, cortisol, 
epinephrine, norepinephrine and vasopressin levels. Activation of Renin-
Aldosterone-Angiotensin system also occurs. Neuraxial blockade can 
partially suppress or totally block the neuroendocrine stress response. To 
maximize this blunting effect, Neuraxial blockade should preceed 
incision and continue into the postoperative period. 
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INDICATIONS 
· Lower abdominal surgery 
· Inguinal surgery 
· Urogenital procedures 
· Rectal surgery/Lower extremity surgery. 
CONTRAINDICATIONS 
ABSOLUTE 
· Raised intracranial pressure 
· Coagulopathy/blood dyscrasias 
· Skin sepsis 
· Severe mitral stenosis/aortic stenosis 
· Patients refusal 
· Hypovolemia 
        RELATIVE 
· Preexisting neurological deficits 
· Severe spinal deformity 
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TECHNIQUE OF SPINAL ANAESTHESIA 
To perform spinal anaesthesia, the technique is divided into four 
steps. 
· Preparation 
· Position 
· Projection 
· Puncture 
PREPARATION 
Preparation of the equipment and drugs is essential for 
subarachnoid injection. The drug chosed should match the duration of 
surgery and the level of blockade needed for the procedure. 
POSITION 
The three primary position includes   
i. The lateral decubitus position 
ii. Sitting position 
iii. Prone position 
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LATERAL DECUBITUS POSITION 
It is the most commonly used position. It allows easier 
administration of sedation and less dependent on a assistant for 
positioning. Patients are placed with their back parallel to the edge of the 
operating table nearest the anaesthesiologist, their thighs flexed on their 
abdomen and their neck flexed to allow the forehead to be as close as 
possible to the knees. 
SITTING POSITION 
This position is ideal in two situations. 
a. Low lumbar and sacral levels of sensory anaesthesia are required 
for the Perineal or Urological procedures. 
b. Obesity or Scoliosis making identification of midline difficult in 
the lateral position. 
When placing the patient in this position, a stool can be provided as 
a footrest and a pillow placed in the lap. The assistant then maintains the 
patient in a vertical plane while flexing the patients neck and arm over the 
pillow to open up the lumbar vertebral space. The assistant prevents the 
patient from slumping laterally 
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PRONE POSITION 
This position is appropriate for Rectal, Perineal and lumbar 
procedures using hypobaric technique. After the patient in position, 
Lumbar lardosis should be minimized and a paramedian approach used. 
The anaesthesiologist may have to aspirate for CSF because CSF pressure 
is minimized when inserting spinal needle in this position. 
PROJECTION AND PUNCTURE 
After proper preparation and patient positioning ,the midline or the 
paramedian spinal puncture can be performed. 
The midline approach relies on the ability of the assistant to 
minimize lumbar lardosis and allow easy access to the subarachnoid 
space between adjacent spinous process, usually L2-L3,L3-L4 or L4-
L5.It is the technique of choice because it requires anatomic projection in 
only two planes and provides a relatively avascular plane. 
The paramedian approach is choosed when there is a difficulty in 
needle insertion with midline approach.The needle is inserted 1cm cauded 
and lateral to the cauded edge of the cephalad spinous process. 
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TAYLORS APPROACH 
                 This is a variation of paramedian approach.It is carried out at 
the L5-S1 space.The needle is inserted in a cephalomedial direction ,1cm 
medial and cauded to the lowermost prominence of the posterior superior 
iliac spine.  
STOUT’S PRINCIPLE FOR SPREAD OF SOLUTIONS: 
1. Height of anaesthesia varies directly with concentration 
2. Extent of anaesthesia is inversely proportional to rapidity of 
fixation 
3. Extent  of  anaesthesia  is  directly  proportional  to  the  speed  of  
injection. 
4. Extent of anaesthesia is directly proportional to the volume of fluid 
5. Extent of anaesthesia is inversely proportional to the spinal fluid 
pressure 
6. Extent of anaesthesia is directly proportional to specific gravity  for 
hyperbaric solution 
7. With hypobaric or hyperbaric solution extent depends upon on 
position of patient. 
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INFLUENCE OF PREGNANCY ON SPINAL ANAESTHETIC 
SPREAD 
Pregnant women in second and third trimester require smaller dose 
of  anaesthetic  agent.  In  1953,  the  influence  of  pregnancy  on  spinal  
anaesthetic dose requirement was reported in Pitkins Conduction 
anaesthesia. 
Two principle factors for the decreased anaesthetic dose 
requirement in pregnant women for SAB are 
i. Mechanical factor 
ii. Hormonal factor 
Compression of Inferior vena cava by gravid uterus causes 
shunting of blood to the venous plexus in the vertebral column. This 
decreses the vertebral canal space and CSF volume, Thus given spinal 
anaesthetic mixture will be more diluted in a small amount of CSF than  
in the non preganant women. 
Hormonal factors for an increased sensitivity of the spinal nerves 
to local anaesthetic agents in pregnancy are  
i. High progesterone level in last trimester 
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ii. Increased endorphine level  
iii. Increased alkalinity of CSF   
FATE OF THE INJECTED DRUG: 
There is a fall in the concentration immediately after injection of 
the agent into the subarachnoid space  due to four pharmacokinetic 
processes 
i. Dilution and mixing in CSF  
ii. Diffusion and distribution to neural tissues 
iii. Uptake  and fixation by neural tissues 
iv. Vascular absorption and elimination through arachnoid 
villi and directly from capillary bed of parenchyma. 
FACTORS AFFECTING SPREAD OF LOCAL ANAESTHETIC 
AGENTS  
1. Patient  age 
2. Height 
3. Patient position 
4. Configuration of spine 
5. Volume of CSF 
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6. Site of injection 
7. Speed of injection 
8. Direction of needle 
9. Local anaesthetic agent baricity 
10. Local anaesthetic agent dose/volume. 
FACTORS NOT AFFECTING CSF SPREAD 
1. Patient weight. 
2. Patient gender. 
3. CSF composition /CSF circulation. 
DISADVANTAGES AND COMPLICATIONS 
1. Controllability- Continuous technique afford a greater margin of 
control and flexibility. 
2. Circulatory disturbances – hypotension occurs with high spinal 
especially above T4 
3. Not suitable for surgery above diaphragm 
4. Respiratory impairment with high spinal level 
5. Traumatic spinal puncture 
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6. Post lumbar puncture sequelae – head ache, cranial nerve 
disturbances(ocular and auditory), infection(meningitis, epidural 
abcess). 
7. Neurological sequelae following injection  
i. Meningismus 
ii. Adhesive arachnoidits 
iii. Cauda equine syndrome/myelitis. 
ADDITION USES OF SPINAL ANAESTHESIA 
(i) Paralytic ileus 
Nonobstructive ileus has been satisfactorily treated with spinal 
anaesthesia 
(ii) Hyperthyroidism 
Spinal anaesthesia to the level of fifth thoracic segment has a 
beneficial effect upon patients in thyroid crisis and thyrotoxic patients 
undergoing surgery. 
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(iii) Pulmonary edema 
The rationale of treatment with spinal anaesthesia is that this 
diminishes venous return to the heart and relieves the cardiac load. 
(iv) Diagnostic test 
For evaluating hypertensive patients, which patients will have a 
successful treatment from sympathectomy. 
(v) Megacolon 
In Hirschsprung disease, spinal anaesthesia has been used to block 
the predominant action by the sympathetic system which causes 
dilatation. 
(vi) Pain evaluation 
Differential spinal blockade may be used to evaluate and 
differentiate functional chronic interactable pain from pain of somatic or 
sympathetic origin. 
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USE OF AN INTRODUCER 
The concept of the introducer for performance of spinal puncture in 
anaesthesia was that of Lincoln Sise. The advantages of the introducer are 
i. prevents deflection of spinal needle by tough supra and 
intraspinous ligament as well as resistant skin. 
ii. Enables the introduction of fine gauge spinal needle into the 
subarachnoid space. 
iii. Safeguard against contamination of subarachnoid space and 
carrying of skin bacteria to the thecal space. 
iv. Avoid skin fragmentation entering subarachnoid space and 
formation of Epithelioma. 
The purpose of the introducer is to enable the entry of the spinal 
needle into the depth of interspace without touching skin, subcutaneous 
tissue and the stiff supraspinous and interspinous ligament. 
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TESTING OF THE SPINAL NEEDLE QUALITY 
The flexibility and the resiliency of the needle is to be tested. The 
hub of the needle is grasped with one hand and the shaft of the needle 
with the other hand.The ends should be depressed gently to make the 
needle bent.On release of the shaft,the needle should spring back to a 
straight position,demonstrating the above properties. 
The needle with the stylet snugly in position,should be thrust 
through a sterile gauze square.If there is a poor matching of the stylet 
with the needle or if a burr is present at  the point of the needle,then a 
thread or two will be caught at the tip. 
  
PHARMACOLOGY	OF	
THE	DRUG	
30 
 
PHARMACOLOGY OF  THE DRUG 
Local anaesthetics are drugs that inhibit sensory,motor or 
autonomic nerve function when injected or applied near the neural tissue. 
These drugs consist of a lipophilic,unsaturated aromatic ring and a 
hydrophilic,tertiary amine separated by a hydrocarbon chain that includes 
an ester or amide linkage.These drugs are weak bases,carrying a positive 
charge at the terminal amine group at physiological pH 
The minimum concentration of local anaesthetic that will block the 
nerve impulse is affected by  
i. Fibre size, type, myelination 
ii. pH     
iii. frequency of nerve stimulation 
iv. electrolyte concentration. 
Onset of action depends on lipid solubility,relative concentration of 
nonionized lipid soluble and ionized water soluble form expressed as 
pKa.Local anaesthetic with pKa closer to physiological pH  will have a 
greater concentration of nonionized base that permeates the nerve cell 
membrane rapidly.  
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BUPIVACAINE 
It is a synthetic drug,prepared by A.F.Ekenstam in 1957 and 
marketed as Marcaine.  
 
· Molecular weight of chloride salt is 325 and that of the base 
is 288. 
· Melting point-258 degree Celsius. 
· pH of the solution with adrenaline is about 3.5 
· The chemical name is 1-n-butyl-DL-piperidine-2-carboxylic 
acid-2,6 dimethylanilide hydrochloride 
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CHEMICAL PROPERTY OF THE DRUG 
· The base is sparingly soluble, the hydrochloride is readily 
soluble in water. 
· The drug is stable and can withstand autoclaving. 
· It is more potent and long acting than lidocaine. 
· Anaesthetic index is 3-4. 
PHARMACODYNAMICS 
The onset of action is between 5-7minutes,maximum anaesthesia is 
obtained between 15-25 minutes. 
PLASMA BINDING 
The drug binds avidly with protein to the extend of 70-90%. 
METABOLISM 
             As its an amide,Liver is the primary site of metabolism mostly by 
alkylation.10% drug is excreted unexchanged in the urine.The high 
protein-binding capacity explains the less diffusion of the drug across the 
placenta 
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MECHANISM OF ACTION 
The drug inhibits passage of sodium ions through ion-selective 
sodium channel in the nerve membrane.It slows the rate of depolarization 
so that the threshold potential is not reached and action potential not 
propagated. 
Bupivacaine blocks the sodium chanel in inactivated closed 
state,and prevent their change to the resting closed and activated open in 
response to nerve impulse. 
The drug also binds to activated open sodium channels to produce 
frequency dependent blockade. 
They also act on voltage dependent potassium channel.Evidence 
suggest that they can act on G-protein coupled receptor also. 
SIDE EFFECTS 
The principal side effects are allergic reactions and systemic 
toxicity due to excessive plasma and tissue concentration of the agent. 
ALLERGIC REACTION 
The Ester local anaesthetics producing metabolites  of para-
aminobenzoic acid evoke allergic rection more than Amide local 
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anaesthetics.Allergic reaction also develop for methylparaben,a 
preservative in commercial preparation. History of 
rash,utricaria,laryngeal edema,with or without bronchospasm and 
hypotension is suggestive of local anaesthetic induced allergic reaction. 
SYSTEMIC TOXICITY   
Excess plasma concentration due to accidental intravascular 
injection or absorption from injection site accounts for systemic toxicity. 
CARDIOVASCULAR SYSTEM (CVS) 
The CVS toxicity is more resistant to treatment than CNS toxicity. 
During diastole,highly lipid soluble bupivacaine dissociates slowly from 
sodium ion channel,thus accounting for persistant cardiac 
toxicity.Ropivacaine is a pure S-enantiomer that is less lipid soluble and 
less cardiotoxic than bupivacaine.Drug toxicity presents as precipitous 
hypotension,arrhythmias and atrioventricular blocks. 
CENTRAL NERVOUS SYSTEM (CNS) 
The  CNS  toxicity  ranges  from  perioral  numbness,  seizures,  CNS  
depression, accompanied by hypotension and apnea. Transient 
neurological symptoms,Cauda Equina syndrome and Anterior spinal 
artery syndrome are documented complications. 
POSTDURAL	
PUNCTURE	
HEADACHE		
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POSTDURAL PUNCTURE HEADACHE 
Apart  from intentional dural puncture in  subarachnoid 
block,epidural   anaesthesia performed for postoperative and labour pain 
relief can result in unintentional dural puncture.However dural puncture 
is a commonly performed invasive procedure for diagnostic lumbar 
puncture,myelography and intrathecal chemotherapy. 
12% claims of malpractice filed against anaesthesiologist providing 
obstetric anaesthesia care were because of postdelivery headache in 
patients who received epidural anaesthesia and probable dural puncture. 
CHARECTERISTICS OF PDPH 
PDPH is 
· dull aching or throbbing in nature. 
· occurs within 7 days of dural puncture. 
· It is self-limiting and disappears within 14 days. 
· It worsens in upright position and eases when supine. 
· Headache is often in occipital region. 
· Pressure over the abdomen with the women in upright position 
may give transient relief to headache by increasing the intracranial 
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pressure secondary to the  increase in intraabdominal 
pressure.(GUTSCHE SIGN) 
CAUSES OF POSTPARTUM HEADACHE 
After delivery, 39% of Parturients report symptoms of headache 
unrelated to dural puncture. There are many causes that mimics PDPH in 
postoperative period that need to be diagnosed as the treatment modalities 
varies.Causes include 
(i) Infective 
Meningitis and encephalitis 
(ii) Vascular causes 
Migraine 
Cerebral vein thrombosis 
Cerebral infarct 
Subdural hematoma 
Subarachnoid hemorrhage 
(iii) Neoplastic 
Space occupying lesion 
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(iv) Pharmacological or metabolic 
Dehydration / Caffeine withdrawal 
(v) Others 
Postdural puncture headache 
Pre-eclampsia 
Tension headache 
Benign intracranial hypertension 
Pneumocephalus 
                 Lactational headache. 
PATHOPHYSIOLOGY OF PDPH 
With  dural  puncture,  there  is  loss  of  CSF  and  lowering  of  CSF  
pressure.Rate of CSF loss is greater than the rate of CSF production 
particularly with spinal needle size greater than 25 gauge.  
Possible explanation for headache includes 
i. Lowering of CSF pressure causes traction on pain sensitive 
intracranial structures like meninges,vessels and cranial 
nerves leading to headache. 
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ii. According to Monro-Kellie Hypothesis,loss of CSF volume 
is compensated by venodilatation resulting in increased 
blood volume. 
INCIDENCE: 
In 1898,the incidence of PDPH was as high as 66% due to larger 
gauge, medium bevel, cutting spinal needles.   
Needle design  Gauge Incidence 
Quincke 22 36% 
25 3-25% 
26 0.3-20% 
27 1.5-5.6% 
29 0-2% 
Whitacre 20 2-5% 
22 0.6-4% 
25 0-14.5% 
27 0% 
Sprotte 24 0-9.6 % 
Atraucan 26 2.5-4 % 
 
               The incidence of PDPH is directly proportional to the gauge of 
the needle and inversely proportional to the experience of the 
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anaesthetist. The incidence is less if the bevel of the needle is oriented 
parallel  to  the  direction  of  dural  fibres.  The  loss  of  resistance  with  air  
increases  the  risk  of  PDPH  than  loss  of  resistance  with  saline  during  
epidural anaesthesia. 
RISK FACTORS 
The risk factors for the development of PDPH may be either needle 
related or patient related. 
The needle related factors are 
i. size of the needle. 
ii. shape of the needle tip. 
Larger the gauge, more is the incidence of PDPH. Fine gauge 
spinal needles have a low incidence of PDPH but are technically more 
difficult to use with high failure rate. Pencil tipped non-cutting needle tips 
are associated with low incidence of PDPH than cutting needle tip. 
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Patient related factors are 
· Age./ 
· Sex. 
· Body mass index. 
· Obstetric population. 
            PDPH is more common in young age group. In children, 
incidence is less because of low reporting rate and low CSF pressure. In 
old age, incidence is less because of the following reasons 
· Decreased elasticity of dural fibres 
· Decreased reactivity of cerebral vessels 
· Decreased A delta and C fibres 
· Attenuated central sensititation. 
· Elevated pain threshold. 
PDPH is  more  common in  Women.In  a  series  report  by  Vandane  
and Dripps,women have twice the incidence as in male.It was found to be 
12% in women and 7% in men. It is stated that the greater incidence is 
because of the larger number of obstetric patients in women group. 
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PDPH is more common in low BMI patients. 
Obstetric patients are at high risk because of their sex,young age 
and the frequency of epidural anaesthesia as a part of labour analgesia. 
SYMPTOMS 
· Postural headache. 
· Neckache 
· Nausea. 
· Vomiting. 
· Tinnitus. 
· Blurring of vision. 
· Hearing loss. 
· Vertigo. 
· Dizziness 
· Paresthesia of the scalp, lower and upper limb pain. 
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DIAGNOSIS 
There is a positive history of accidental or deliberate dural 
puncture. 
Diagnosic LP demonstrates low CSF pressure or a dry tap,a slight 
increase in CSF protein and increase in CSF lymphocyte count. 
MRI shows diffuse dural enhancement with evidence of dural 
sagging,descent of brain,optic chiasma and brain stem,obliteration of 
basal cisterns and enlargement of pituitary. 
CT myelogram, Retrograde Radionuclide Myelography, 
Cisternography can locate the site of dural leak.   
ESTIMATED RATE OF SPONTANEOUS RECOVERY 
DURATION % RECOVERY 
1-2 days                                            27 
3-4days                                             39
5-7days                                             19
8-14 days                                           8 
3-6weeks                                           5
3-6months                      2
7-12months                                       4
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             The largest follow-up of PDPH is still that of Vandam and Dripps 
et al in 1956.They reported that  72%  headache resolved within 7 days 
and 87% within 6 months. 
TREATMENT 
1. Adequate hydration is to be maintained.Studies have been done to 
know effect of preloading with PDPH and found that Preloading 
cannot prevent PDPH.Its better to maintain adequate hydration 
than dehydration. 
2. Most  of  the  patients  respond  to  simple  analgesics  like  
NSAIDS,Acetaminophen. 
3. Supportive treatment like antiemetics can be given. 
4. Prone posture increases intraabdominal pressure and epidural 
pressure.A clinical trial of prone position following dural puncture 
failed to demonstrate any decrease in PDPH. 
5. Pharmacological treatment includes 
i. Caffeine 
ii. Cosyntropin(ACTH analogue) 
iii. Sumatriptin(5HT1D Receptor agonist) 
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(i) CAFFEINE 
               It is a CNS stimulant,produces cerebral vasoconstriction,blocks 
peripheral adenosine receptors and other central mechanisms.It is given 
as Caffeine sodium benzoate orally or intravenously.Dose is 500mg 
orally or 500mg in one litre intravenous fluid iv over one hour. 
The most frequently quoted work on treatment of PDPH with 
caffeine is that of Sechzer. He concluded that iv caffeine is an effective 
treatment for PDPH. 
The side effects of caffeine are 
· CNS Stimulation. 
· Seizures. 
· Gastric irritation. 
· Cardiac arrhythmias. 
Treatment with caffeine does not decrease CSF leak nor restores 
normal CSF dynamics,therefore the recurrence rate is 60%. 
(ii) COSYNTROPIN 
It is an ACTH analogue, less antigenic than naturally occurring 
harmone. It stimulates adrenal cortex to secret glucocorticoids, 
mineralocorticoids and weak androgens. It activates adenyl cyclase, with 
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resultant increase in intracellular cyclic AMP. Increased CSF production 
through a sodium active transport mechanism, as well as possible 
increase in beta endorphin in CNS, increased pain threshold are the 
possible mechanism of action. 
Dose is 0.25-0.75mg intravenous.  
(iii) SUMATRIPTAN 
It is a 5HT1D receptor agonist. Carp et al reported administration 
of sumatripten 6mg to six patients with headache within six hours and 
reported good results. 
EPIDURAL BLOOD PATCH 
Introduced by Gormley in 1960.usually performed for severe 
headache not responding to conservative management after 24 hours. 
Contraindication includes  
· Fever 
· Coagulopathy 
· Infection at the site 
· Patients refusal. 
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Blood samples to be sent for microbiology for culture before 
proceeding for the procedure. Patient is placed in lateral position,epidural 
space identified with tuohy needle at the level of supposed dural puncture 
or one space below. Two persons are required to perform the technique. 
One person identifies  Epidural  space while the other draws 10-20 ml of  
blood under aseptic precaution. Withdrawn blood is injected into the 
epidural space at the rate of one ml every three seconds. The injected 
blood clots and seals the dural rent and the compressed dural space 
restores the subarachnoid pressure. The injection should stop if the 
patient experiences lancinating pain or backache. The patient should lie 
flat on the back for one or two hours, then allowed to walk. 
Complication of this invasive technique is that of 
· Backache 
· Infection,arachnoiditis 
· Failure of treatment. 
EPIDURAL SALINE/DEXTRAN 
Saline is relatively inert and sterile. It can be given as bolus or 
infusions. Some of the recommendations are  
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· 1 to 1.5 litres of epidural hartmann solutions over 
24hours,starting on day 1 after spinal anaesthesia. 
· Upto 35ml/hr for 24 hours on development of headache. 
· Single 30ml epidural bolus after development of headache. 
· 10-120ml of saline injected as bolus via caudal epidural 
space. 
EPIDURAL,INTRATHECAL,PARENTERAL OPOIDS 
Majority of the studies on use of morphine is either case reports or 
inadequate controlled trials. 
FIBRIN GLUE 
Fibrin glue is a preparation of pooled human plasma obtained from 
plasmapheresis. It is prepared by mixing two solutions. First one contains 
fibrinogen, factor VIII, fibronectin ,aprotinin, plasminogen. The second 
one contains thrombin and calcium. The mixture forms a gel with high 
tensile strength. It is applied blindly or CT- guided percutaneous 
injection. Complication includes risk of Aseptic meningitis. 
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INTRATHECAL CATHETERS 
The placement of spinal catheters through the perforation may 
provoke an inflammatory reaction that will seal the hole.Complication 
include risk of Cauda equina syndrome and infections. 
NUMBER OF ATTEMPTS 
Lybecker et al didn’t support a association between frequency of 
PDPH and the number of dural puncture.But recent prospective analysis 
of SAB performed on 8034 patients showed increased incidence of PDPH 
with repeated attempts. 
FAILED  SPINAL ANAESTHESIA 
Though spinal anaesthesia is safe,cost effective and reliable 
technique commonly used,failed spinal block is a possibility  if the 
technique is not performed meticulously.Inadequate/failed spinal 
anaesthesia is very difficult to manage. 
Two  factors  are very important determinant of a successful 
blockade.They are 
i. Dural puncture 
ii. Deposition of the drug in correct dose into the thecal space. 
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Spinal anaesthesia is technically easy procedure with a clear cut 
end point,the CSF.The appearance of CSF at the needle hub gives us an 
indication that we are in the thecal space.At the same time,appearance of 
CSF alone doesn’t guarantee successful blockade. 
Failed block can be of three types, namely 
i. Inability to get a flow of CSF,called as Dry tap. 
ii. subarachnoid block attempted,no resultant block. 
iii. Block ensues,but inadequate for the extend and qualityof 
anaesthesia  and duration of surgery. 
Failure of spinal anaesthesia is avoidable provided the technique is 
performed properly. With experienced hands,incidence of failed spinal is 
less than 1% 
There are five phases of spinal anaesthesia which can influence the 
failure incidence. They are 
i. Lumbar puncture 
ii. Injection of the drug 
iii. Spread of the drug 
iv. Action of the drug 
v. subsequent patient management. 
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LUMBAR PUNCTURE 
The problems encountered during lumbar puncture are due to two 
factors, 
· poor positioning of the patient 
· incorrect needle insertion 
Abnormalities of the spine like kyphoscoliosis and calcification of 
the ligaments, obesity, patients anxiety  plays a role in poor positioning of 
the patient. 
The spinal needle is inserted in midline, midway between the 
posterior spines.The shaft of the needle is placed at right angle to the back 
of the patient.When there is resistance to insertion,the needle is angulated 
in cephalad direction.While  advancing the needle,a mental picture of the 
spinal anatomy helps to appreciate where the needle tip lies. 
INJECTION OF THE DRUG 
The drug should be injected into the thecal space for a successful 
blockade.Anterior or posterior displacement of the spinal needle while 
attaching the syringe to the needle or while injecting the drug can result 
in an inadequate block or failed spinal.With pencil tip needles,the 
opening is proximal to the tip.Slight backward movement can result in 
51 
 
loss of drug injected into the epidural space and a forward movement can 
elicit parasthesia by the tip contacting the nerve fibres. 
SPREAD OF THE DRUG 
The CSF acts as a medium through which the drug acts.The spread 
of the drug is dependent on the baricity of the drug injected,position of 
the operating  table and the anatomical abnormality of the vertebral canal. 
PATIENT FACTOR 
Surgical stimulus  can stimulate the unblocked parasympathetic 
and phrenic nerve ,making the patient anxious.The patients should be 
explained the technique to be performed and what to expect before 
proceeding to surgery. 
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Figure 7 & 8 :- Position of the Needle Tip 
REVIEW	OF	
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REVIEW OF LITERATURE 
HISTORY OF SPINAL ANAESTHESIA 
In 1885,Leonard Corning,a Newyork Physician,accidentally 
injected cocaine intrathecally in a dog.He proposed that local anaesthesia 
of the spinal cord with cocaine may have therapeutic property.He injected 
cocaine in a man at the level of T11-T12 interspace to treat seminal 
incontinence.He coined the term SPINAL ANAESTHESIA. 
In 1891,Wynter and Quincke aspirated CSF from subarachnoid 
space to treat increased ICT associated with TB meningitis. 
In 1898,Karl August Bier,a german surgeon and his assistant 
Hildebrandt underwent spinal anaesthesia with cocaine,the assistant first 
injecting Bier and then Bier his assistant.While injecting the assistant 
struggled to connect the syringe to the needle,resulting in significant loss 
of CSF.He developed severe headache and he correctly noted that the 
headache was related to the loss of CSF. 
In 1901,a swiss obstetrician used intrathecal cocaine for pain relif 
in second stage of labour.Though high incidence of both vomiting and 
PDPH noted,a high mortality rate in LSCS performed under subarachnoid 
block led to abandon the technique in 1930.The period from 1930-1950 is 
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referred to as Dark Age Of Obsteric Anaesthesia,when natural child birth 
and psychoprophylaxis were encouraged. 
Development of fine gauge spinal needles and needle tip 
modification has enabled a significant reduction in the incidence of 
PDPH. 
HISTORY OF SPINAL NEEDLES 
The development of spinal needles and needle tip modification 
began with the understanding of anatomy and physiology of CNS that 
pertained at the time of introduction of spinal anaesthesia. 
In 1841,Zophar jayne of illinos designed a syringe attached to a 
small sharp,hollow beak with an opening on the side near the tip. 
In 1853,Alexander Wood of Edinburg is credited the first in 
developing hollow hypodermic needle. He used Fergusons needle for 
injecting into deeper structure. 
In 1885,Leonard Corning developed his own needle made of gold 
or platinum. cannula was flexible with a metal stop and a set of screw to 
fix the needle at correct place once the subarachnoid space has been 
entered. Tip is sharp,short cutting bevel.Introducer was short with a right 
angled handle.                                     
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Bier took a historic step of using spinal anaesthesia to provide analgesia 
for surgical procedure. He designed a large bore needle,15gauge or 
17gauge that needed no introducer. It has a long cutting bevel and a sharp 
tip. Biers needle was criticized for causing pain on injection and leaving a 
large hole in dura. 
 
Figure 10 : Bier's Needle 
 
Bainbridge in 1900,described a needle with a small circular hub,a 
short sharp cutting bevel and a stylet with a matching bevel,made of 
flexible metal. 
Barker appreciated the problem with long bevel and he designed a 
hollowed out point to secure sharpness without lengthening the terminal 
opening.Barkers needle is 18 gauge or 19 gauge with a medium length 
bevel and a stylet with a matching bevel. 
Figure 9 : Corning Needle 
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In 1914,Babcock described a sharp,medium length bevel with the 
matching stylet,made of iridized pplatinum or gold.It was 20 gauge in 
diameter and referred as Quincke babcock needle.It was a very successful 
needle and became the standard needle for comparative studies. 
 
Figure 11 : Quincke Babcock Needle 
 
Gaston labot needle was a medium gauge cannula with a 
short,sharp bevel and a matching stylet. The tip ground to match the bevel 
of the cannula. 
ATRAUMATIC SPINAL NEEDLE TIPS 
In 1920,realization of the fact that CSF leak is associated with 
cutting of duramater led to the development of needle tip modifications. 
In 1923,Hebert Morton Greene used an ordinary 23 gauge cutting 
needle that he shaped to a rounded tip by removing the cutting edge of the 
bevel.The needle was sized between 20gauge and 26 gauge.The point was 
a rounded,non-cutting bevel of medium length with a matching,bevelled 
fitted stylet.It was very popular in obstetric practice till the invent of 
Whitacre needle in 1951. 
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MODIFICATION OF CUTTING BEVEL 
Pitkin needle is 20gauge or 22 gauge,made of relatively flexible 
rustproof steel with a collar to mark the depth of insertion.Tip has 
short,sharp bevel ground off to a taper of 45 degrees,resulting in rounded 
blunted bevel heel.He advocated the insertion of cutting edge of the bevel 
parallel to the longitudinal fibres of dura. 
PENCIL POINT NEEDLES 
Barker was credited the first directional closed-end spinal 
needle,which forms the basis of pencil-point tip used commonly 
nowadays. 
Hart and Whitacre designed a closed ended,lateral orifice,pencil 
point tip needle in 1951.It is a 20 gauge needle with a solid end drawn to 
a point similar in shape toa finely sharpened pencil.These needles have 
decreased incidence and severity of PDPH and a more appreciable dural 
click.The needle has a small hole making aspiration and injection 
difficult. 
 
Figure 12 : Whitacre Needle 
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CONTINOUS SPINAL NEEDLE 
Various spinal needle were described in literature. 
· Lemmon needle 
· Hingson Fegurson needle 
· Tuohy needle 
· Cappe and Deutsch needle. 
SPROTTE NEEDLE 
It is a modification of Whitacre needle. It has increased size of 
lateral  orifice to combat the problem of slow CSF flow and resistance to 
injection. The tip is also elongated in an attempt to allow more gradual 
separation of dura. 
 
Figure 13 : Sprotte Needle 
 
  
59 
 
ATRAUCAN NEEDLE 
In 1993,Atraucan needle has a cutting double bevel with a sharp 
point making an initial incision. The second part then dilates the incision 
rather than cutting leaving a small hole in the dura. 
DOUBLE HOLE PENCIL-POINT NEEDLE 
Eldor in 1996 was based on pencil point tip but with two lateral 
holes opposite to each other. 
 
Figure 14 : Eldor Needle 
 
BALLPEN NEEDLE 
It’s a modification of Quincke needle designed in 2000.This needle 
is similar to Levy needle of 1957.Advantages of the needle are  
i. tip of the needle is always in the subarachnoid space on removal 
of stylet 
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ii. needle tip doesn’t project beyond the orifice to cause 
neurological damage 
iii. no mechanical weakning at the tip caused by the presence of 
lateral opening. 
 
Figure 15 : Ball Pen Needle 
 
Shutt Le et al in 1992,compared the incidence of PDPH in 150 
obstetric patients using 26gauge Quincke,22gauge Whitacre and 25 gauge 
Whitacre needles.The problem with the study was that the power of study 
was not disscussed.Power of study estimated by Altmans nomogram is 
0.55 which is too low to expect a significant result.They stated difference 
in the incidence of headache was statistically insignificant.The incidence 
of PDPH was 4% with Quincke needle and 1% with Whitacre 
needle.(Br.J.Anaesth;1992,69:589-94) 
A study includes 300 patients posted for lower limb/ortho 
surgery.They were allotted into 3 groups.Group 1 had SAB with 25 gauge 
Quincke needle, with bevel oriented perpendicular to the fibres.Group 2 
had SAB with 25 gauge Quincke, with bevel oriented parallel to the dural 
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fibres.Group 3 had SAB with 24 gauge Sprotte.The incidence of PDPH 
was 17.9%,4.5% and 2.4% respectively.The results shows that Quincke 
needle should not be inserted perpendicular to the dural fibres and tha 
Sprotte needle does not solve the problem of PDPH or 
backache.(Reg.Anaesth 1992;17(5):283-7)  
A study comparing 24 gauge Sprotte and 25 gauge Quincke spinal 
needle showed lower incidence of severe PDPH with 24 gauge Sprotte 
but was not significantly different when compared with 25 gauge 
Quincke spinal needle.In this study,194 patients were allotted into group 
1(n-96,Sprotte) and group 2(n-98,Quincke).Fentanyl was given 
intrathecally in 47 patients in group 1 and 49 patients in group 2.All 
patients followed for 4 days postoperatively for headache.Incidence of 
PDPH was found to be 4.2% in Sprotte group and 7.1% in Quincke 
group.(Reg Anaesth 1993;18:222-5) 
Campbell et al in 1993,studied in 300 patients with 24 gauge 
Sprotte and 25 gauge Whitacre needle.Each group includes 150 
patients.The incidence of PDPH is 4% with sprotte needle(6/150) and 
0.66% with whitacre needle(1/150).(Can.J.Anaesth 1993;40(12):1131-5) 
A study of 400 patients, comparing 25 gauge Whitacre and 25 
gauge Quincke spinal needles showed 3%(p<0.02) incidence with 
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Whitacre and 8.5% with Quincke needle.No significant difference in age 
or sex in both groups.The duration lasted for 1-3 days in Whitacre group 
and 1-9 days in Quincke group.(Reg Anaes.1993;18:166-9)  
The frequency and severity of headache after Lumbar myelography 
using 25 gauge Whitacre in 63 patients aged 20-81 years showed an 
incidence of 4.7%.3 patients had PDPH.(Neuro radiology 1995;37:553-6) 
Incidence of PDPH was 4% with 26 gauge Atraucan and 4.3% with 
25 gauge Whitacre spinal needle in a study.Use of 26 gauge helps in 
better identification of subarachnoid space,faster CSF back flow and 
fewer parasthesia.(Can J Anaesth 1995;42:706-10) 
Lambert et al reported the rate of PDPH with 25gauge Whitacre as 
1.2%, 2.7% with 27gauge Quincke cutting needle and 5.2% with 26 
gauge Quincke needle. He included 4125 patients over 4 years 
period.(Reg.Anesth 1997;22(1):66-72) 
In Acta Anaesthesiology Scand 1997;41:779-84,200 patients 
posted for day care procedure were studied for the severity and incidence 
of PDPH in using 27 gauge Quincke and 27 gauge Whitacre.Incidence of 
PDPH  is  0%  with  27  gauge  Whitacre  spinal  needle  and  5.6%  with  27  
gauge Quincke needle.All PDPH occurred with Quincke needle oriented 
perpendicular to the duramater. 
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Hwang JJ,HOST et al in 1995,studied 90 patients with 26 gauge 
Quincke and 25 gauge Whitacre needle.Incidence of PDPH was 6.66% 
with Quincke and 1.52% with Whitacre. 
Jost u et al in 2000,studied 600 patients using 26 gauge Quincke 
and 27 gauge Whitacre. Incidence of PDPH was 6% with Quincke and 
1% with Whitacre. (Anasthesiol Intensive Med;2000,35:381-7) 
Vallejo  et  al  studied  the  incidence  of  PDPH  and  Epidural  Blood  
Patch using 5 spinal needles in obstetrics.He used 2 cutting needle(26 
gauge atraucan and 25 gauge Quincke) and 3 pencil point needles(24 
gauge Gertie Marx,24 gauge Sprotte,25 gauge Whitacre).The incidence 
of PDPH and EBP are 5%, 8.7%, 4%, 2.8%, 3.1% and 55%, 66%, 12.5%, 
0%, 0% respectively. (Anaesthesia and Analgesia 2000;91-4:916-920) 
Invitro study of the dural lesion evaluated by scanning electron 
microscopy was done while using 25 gauge Quincke and 25 gauge 
Whitacre.T11-L4 dural membrane from 5 fresh male patients declared 
brain dead,aged 23,46,48,55 and 60 were excised by anterior 
laminectomy.100 punctures (20 on each samples) at 90 degrees made.50 
with 25 gauge Quincke and Whitacre each. It is shown that the dural hole 
is clean cut with Quincke and lacerated with Whitacre needle.This 
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accounts for more inflammation seen with Whitacre needle and therefore 
better healing.(Reg Anaesth Pain Med 2000;25:393-402) 
Landau R et al in 2001,studied 400 patients with 25 gauge 
Whitacre and 27 gauge Whitacre needle.The incidence of PDPH was 
1.32% with 25gauge and 0.03% with 27gauge Whitacre 
needle.(Int.J.Obstet Anaesth;2001,10:168-71) 
75 female patients scheduled for LSCS were grouped into 3 of 25 
each.Group 1,2,3 received SAB using 25 gauge Quincke,27 gauge 
Quincke and 27 gauge Whitacre needles respectively.The patients were 
assessed for  the severity of  PDPH and the technical  difficulties  with the 
needle insertion.All the patient had mild form of PDPH.25 gauge needle 
had 100% successful dural puncture and 27 gauge Whitacre had 12% 
failure rate.(Indian J.Anaesth 2002;46(5):373-377) 
Tabedar in 2006,studied 60 patients with 25 gauge Quincke and 
26gauge Whitacre needle. Incidence was 8% with Quincke and 2.2% with 
Whitacre. (Kathmandu Uni. Med.J;2003,1:263-6) 
Bano F et al in 2004,studied 100 patients with 25 gauge Quincke 
and 25gauge Whitacre.The incidence of PDPH was 4% with Quincke and 
0.75% with whitacre.(Dow University of Health science 
hospital,Karachi;2004,14:647-50)  
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In a study 480 obstetric patients were included as group 1-(25 
gauge Quincke,n-168),group 2(27 gauge Quincke,n-160)and group 3(27 
gauge Whitacre,n-152). The study comparing 25 gauge Quincke,27 gauge 
Quincke and 27 gauge Whitacre needle showed the incidence of PDPH as 
8.3%(14/168) with 25 gauge Quincke,3.8%(6/160) with 27 gauge 
Quincke,2%(3/152) with 27 gauge Whitacre needle.The severity of 
PDPH was mild in 5,moderate in 7 and severe in 2 patients in group 1.In 
group 2,it was mild in 2,moderate in 3 and severe in 1 patient.In group 
3,2 patients had mild headache and 1 patient had moderate 
headache.(Med Coll Abottabad 2008;20:10-3) 
  
MATERIALS	AND	
METHODS	
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MATERIALS AND METHODS 
The study is to compare the incidence and severity of 
PDPH,number of attempts for successful block and number of failed 
spinal in using 25 gauge Quincke and 25 gauge Whitacre spinal needles 
in 240 obstetric patients after getting approval by the Institutional Ethical 
Committee.It is a double blind study where the patient is unaware of the 
needle type used and the postoperative assessment of headache is done by 
a person unaware of the needle type used. 
The  study  was  done  in  the  Department  Of  
Anaesthesiology,Institute of Social Obstetrics,Government Kasthurba 
Gandhi Hospital for Child and Women,Triplicane,Chennai-5. 
240 obstetric patients posted for elective LSCS under 
Subarachnoid block were randomly allocated into group A and group B 
by using a computer generated randomization table . 
SELECTION CRITERIA 
INCLUSION CRITERIA 
· Age 20 to 36 years. 
· Weight 58 to 87 kilograms. 
· Height 148 to 170 cms. 
· ASA 1 ,2 
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· Elective surgery 
· Valid informed consent. 
EXCLUSION CRITERIA 
· Not satisfying inclusion criteria 
· Lack of Written informed consent. 
· Contraindication for neuraxial anaesthesia. 
· H/O Recurrent headache in the past. 
· H/O Occipital neuralgia/Migraine. 
PROCEDURE 
PREOPERATIVE EVALUATION 
A thorough history taking and clinical evaluation done to include 
patients who satisfy inclusion and exclusion criteria.Preoperative 
investigations done as all cases posted for elective surgery.All patients 
were briefed about the nature of the study,procedure to be performed and 
a valid written informed consent obtained. 
The patients were instructed fasting from midnight, atleast for 8 
hours. 
The patients transported to the operation theatre in left lateral 
position.Monitors of pulseoximeter,electrocardiogram(ECG) and non-
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invasive blood pressure(NIBP) attached before performing subarachnoid 
block and monitored throught out the procedure.An intravenous access 
established over the dorsum of left hand with 18 gauge 
venflon.Preloading with 20ml/kg of Ringer lactate done for all 
patients.Premedication with injection Ranitidine and injection 
metaclopramide given one hour prior to surgery. 
               240 patients were randomly allocated into group A and group B. 
Group A patients received subarachnoid block with 25 gauge 
Whitacre needle and Group B received SAB with 25 gauge Quincke  
needle. 
After preloading,patients were placed in right lateral position.The 
back of the patient was cleaned with Povidone iodine and spirit and 
draped  with  sterile  towel.A  skin  wheel  was  raised  with  2ml  of  2%  
Lignocaine and SAB performed with 10mgs of 0.5% hyperbaric 
bupivacaine at L3-L4 space.The patient was turned supine after giving 
the drug,with a wedge under the right hip. 
Anaesthesia considered adequate when the sensation to cold is lost 
at the level of T4,tested with alcohol.Oxygen administered with Hudsons 
mask at 4litres/min throught the procedure.Mean blood pressure 
monitored every five minutes intervals and any decrease more 20% from 
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baseline was treated with a 100ml bolus of  crystalloids and incremental 
bolus of 6mgs intravenous Ephedrin. 
10units Syntocinon administered as intramuscularly and as 
intravenous infusion after the delivery of the baby. 
In case of failure of SAB or inadequate analgesia,patients were 
administered General anaesthesia.Failure of block is defined as either an 
inability to produce a free flow of CSF after three attempts or inadequate 
analgesia for surgery at 15 minutes after giving the local anaesthetic 
agent. 
The number of attempts required for successful blockade was also 
noted for both the type of needles. 
Postoperatively all the patients were enquired about the 
onset,charecteristics,duration,severity and associated symptoms of any 
headache for three days.PDPH is charecterised by postural 
headache,aggrevated by sitting or standing and relieved by lying supine.It 
may be dull aching or throbbing,mostly in the occipital or frontal 
region,accompanied by nausea,vomiting,neck stiffness,diplopia and 
tinnitus. 
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The patients with features suggestive of PDPH were treated with iv 
fluids,bed rest and oral paracetamol 15mgs/kg ,four times daily. 
The severity of headache was categorized as follows 
· Mild PDPH  
Slight restriction of physical activity,these patients are not 
restricted to bed and had no associated symptoms. 
· Moderate PDPH 
The patient is forced to stay in the bed for part of the day, resulting 
in restricted physical activity, not necessarily associated with symptoms. 
· Severe PDPH 
The patients were bedridden for most of the day, associated 
symptoms always present. 
STATISTICAL ANALYSIS 
Descriptive statistics was done for all data and suitable statistical 
tests of comparision were done.Unpaired t-test was used for continuous 
variable and Chi-square Test and Fischer Exact test were used for 
categorical variables analysis. 
RESULTS	
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OBSERVATION AND RESULTS 
 
Treatment 
Groups 
Name of 
Group 
Treatment 
Number of 
Subjects 
Group A 25 GW 
PDPH using pencil-point 
25G Whitacre spinal needle 
in obstetric patients 
120 
Group B 25 GQ 
PDPH usingCutting 
bevelled 25 G quincke  
spinal needle in obstetric 
patients 
120 
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Statistics 
Descriptive statistics was done for all data and suitable statistical 
tests of comparison were done. Continuous variables were analysed with 
the unpaired t-test and categorical variables were analysed with the Chi-
Square Test and Fisher Exact Test. Statistical significance was taken as P 
< 0.05. The data was analysed using EpiInfo software (7.1.0.6 version; 
Center for disease control, USA) and Microsoft Excel 2010. 
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Sample Size Calculation 
Sample size was determined on the basis of a pilot study in which 
the incidence of Post Dural Puncture Headachewas measured as 18%.  
We calculated a minimum sample size of 113 patients was required in 
each group, assuming a type 1 error (two-tailed) of 0.05 and a margin of 
error of 5%. Therefore, the final sample selected was n=120 in Group A 
and n=120 in Group B.  
n= t² x p(1-p) 
 m² 
Description: 
n = required sample size 
t  = confidence level at 95% (standard value of 1.96) 
p = estimated prevalence of malnutrition in the project area 
m  =  margin of error at 5% (standard value of 0.05) 
 
n = (1.96)² x 0.18(1-0.82) 
            (0.05)² 
 
n = 3.8146 x 0.1476 
  
0.0025 
 
= 226 
 
=113 per group 
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AGE 
 
 
Age Distribution 25GW % 25GQ % 
≤ 25 75 62.50 71 59.17 
26 to 30 41 34.17 40 33.33 
> 30 4 3.33 9 7.50 
Total 120 100 120 100 
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25GW 25GQ 
N 120 120 
Mean 25.00833 25.03333 
SD 2.891587 3.159442 
P value 
Unpaired t test 
0.94907 
 
By conventional criteria the association between the Spinal Needle 
groups and age is considered to be not statistically significant since p > 
0.05. 
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HEIGHT 
 
 
 
Height Distribution 25GW % 25GQ % 
141 to 150 18 15.00 14 11.67 
151 to 160 91 75.83 96 80.00 
161 to 170 11 9.17 10 8.33 
Total 120 100 120 100 
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25GW 25GQ 
N 120 120 
Mean 155.4333 155.7083 
SD 4.166157 4.013414 
P value 
Unpaired t test 
0.603023 
 
By conventional criteria the association between the Spinal Needle 
groups and Height is considered to be not statistically significant since p 
> 0.05. 
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WEIGHT 
 
 
Weight Distribution 25GW % 25GQ % 
41 to 50 7 5.83 1 0.83 
51 to 60 35 29.17 46 38.33 
61 to 70 63 52.50 56 46.67 
71 to 80 13 10.83 16 13.33 
81 to 90 2 1.67 1 0.83 
Total 120 100 120 100 
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25GW 25GQ 
N 120 120 
Mean 63.85833 63.51667 
SD 7.515022 6.713818 
P value 
Unpaired t test 
0.710668 
 
By conventional criteria the association between the Spinal Needle 
groups and Weight is considered to be not statistically significant since p 
> 0.05. 
Since age, height and weight are not statistically significant, it 
means that there is no difference between the groups. In other words the 
groups contain subjects with the same basic demographic characteristics. 
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GESTATIONAL AGE 
 
 
Gestational Age 25GW % 25GQ % 
37 Weeks 9 7.50 2 1.67 
38 Weeks 67 55.83 42 35.00 
39 Weeks 32 26.67 55 45.83 
40 Weeks 12 10.00 21 17.50 
Total 120 100 120 100 
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25GW 25GQ 
N 120 120 
Mean 37.88542 38.31083 
SD 3.586618 3.60578 
P value 
Unpaired t test 
0.3604 
 
By conventional criteria the association between the Spinal Needle 
groups and Gestational age is considered to be not statistically significant 
since p > 0.05. 
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POST DURAL PUNCTURE HEADACHE FREQUENCY 
 
 
Post Dural Puncture 
Headache Frequency 
25GW 25GQ Total -Row 
PDPH - 116 107 223 
PDPH + 4 13 17 
Total - Column 120 120 240 
chi-square 5.13  
degrees of freedom 1 
P value 
Chi-squared test 
0.024 
116
4
107
13
0
20
40
60
80
100
120
140
PDPH - PDPH +
N
um
be
r o
f S
ub
je
ct
s
PDPH
Post Dural Puncture Headache Frequency
25GW
25GQ
83 
 
Severity of Post Dural 
Puncture Headache 
25GW 25GQ Total -Row 
Mild 2 4 6 
Moderate 1 7 8 
Severe 1 2 3 
Total - Column 4 13 17 
chi-square 1.02 
degrees of freedom 2 
P value 
Chi-squared test 
0.600 
 
Onset of Post Dural 
Puncture Headache 
25GW 25GQ Total -Row 
1st POD 0 0 0 
2nd POD 3 9 12 
3rd POD 1 4 5 
Total - Column 4 13 17 
chi-square 0.327  
degrees of freedom 2 
P value 
Chi-squared test 
0.849 
 
By conventional criteria the association between the Spinal Needle 
Groups and Post Dural Puncture Headache is considered to be statistically 
significant since p < 0.05.  
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Statistical Significance 
This indicates that there is a true difference among groups and the 
difference is significant. . In simple terms, inobstetric anaesthesia, the 
incidence of PDPH is less when pencil-point 25G Whiteacrespinal needle 
is used compared to Cutting bevelled 25G Quincke spinal needle. It is 
statistically significant with a p-value of 0.005 according to Chi-squared 
Test. 
Clinical Significance 
· The occurrence of PDPH was meaningfully less (3.3%) when 
pencil-point 25G Whiteacrespinal needles is used compared to 
Cutting bevelled 25G Quincke spinal needle (10.8%).  
· It was mild in 6%, moderate in 12% and severe in 6% of patients in 
pencil-point 25G Whiteacrespinal needle group. It was mild in 
29%, moderate in 35% and severe in 12% of patients in Cutting 
bevelled 25G Quincke spinal needle group.  
This difference is true and significant and has not occurred by 
chance. 
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NUMBER OF ATTEMPTS 
 
 
Number of 
Attempts 
25GW % 25GQ % 
1 109 90.83 109 90.83 
2 9 7.50 11 9.17 
3 2 1.67 0 0.00 
Total 120 100 120 100 
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25GW 25GQ 
N 120 120 
Mean 1.108333 1.091667 
SD 0.36197 0.289765 
P value 
Unpaired t test 
0.6941 
 
By conventional criteria the association between the Spinal Needle 
groups and number of attempts is considered to be not statistically 
significant since p > 0.05. 
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FAILURE OF SAB 
 
Failure of SAB 25GW % 25GQ % 
Failed - 117 97.50 119 99.17 
Failed + 3 2.50 1 0.83 
Total 120 100 120 100 
chi-square 1.02  
degrees of freedom 1 
P value 
Chi-squared test 
0.313 
 
By conventional criteria the association between the Spinal Needle 
groups and failure of SAB is considered to be not statistically significant 
since p > 0.05. 
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ACCOMPANYING SYMPTOMS 
 
Accompanying 
Symptoms 
25GW % 25GQ % 
Nil 116 96.67 120 100.00 
Nausea 2 1.67 0 0.00 
Vomiting 2 1.67 0 0.00 
Total 120 100 120 100 
chi-square 2.91  
degrees of freedom 2 
P value 
Chi-squared test 
0.233 
 
By conventional criteria the association between the Spinal Needle 
groups and accompanying symptoms is considered to be not statistically 
significant since p > 0.05. 
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DISCUSSION 
The International Association  Of Pain has defined Pain as “A 
conscious sensation of distress, suffering or agony with actual or atleast 
potential tissue damage’’. 
An Anaesthesiologist is one who renders the patient insensitive to 
pain.SAB is the commonest technique performed for LSCS.The pregnant 
patients are more prone for PDPH because of their young age,gender and 
greater use of  walking Epidural technique. 
As  already  stated,  PDPH  is  due  to  loss  of  CSF  through  the  dural  
puncture. This leads to lowering of CSF pressure causing traction on 
intracranial painful structures. There is a compensatory increase in 
intracranial blood volume according to Monro-Kellie Hypothesis. 
Development of fine gauge spinal needles and needle tip 
modification has reduced the incidence of PDPH. Technical difficulty in 
identifying the space and risk of failed blocks should be balanced against 
the morbidity associated with PDPH. 
Now-a-days 25gauge,26gauge and 27 gauge needles are 
recommended for SAB. Needles of 29 gauge or less are associated with 
increased failure rate and therefore not recommended. 
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Many studies favour Pencil tip or non-cutting type of needle for 
reducing the incidence and severity of PDPH. 
In a study conducted in 300 patients,Campbell et al demonstrated a 
PDPH incidence of 0.66%(1/150)  with 25gauge Whitacre needle. 
Hwang JJ,HO ST et  al  demonstrated the incidence to be less with 
25 gauge Whitacre in 90 women posted for LSCS. 
In  a study conducted by Vallejo et al in 1002 obstetric 
patients,using 5 types of spinal needle showed a reduced incidence and 
severity of PDPH with 25 gauge Whitacre needle. 
Bano F et al showed an incidence of 0.75% with 25 gauge 
Whitacre in study involving 100 women. 
My  study  is  to  compare  the  incidence  of  PDPH  with  25  gauge  
spinal needle which is  in common use. The study included 25 gauge 
Quincke and 25 gauge Whitacre needle. 
In the present study of 240 obstetric patients, Age, Height, Weight, 
Gestational age are not statistically significant and are comparable. 
The occurrence of PDPH was less with 25 gauge Whitacre (3.3%) 
than 25gauge Quincke(10.8%).It was mild in 6%,moderate in 12% and 
severe  in 6% in 25 gauge Whitacre group.PDPH is mild in 
29%,moderate in 35% and severe in 12% in 25 gauge Quincke group. 
SUMMARY	
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SUMMARY 
              In summary, a randomized study in comparing the incidence of 
PDPH in obstetric patients posted for Elective LSCS, Using 25 gauge 
Quincke and 25 gauge Whitacre spinal needles showed the following 
results 
· The occurrence of PDPH was meaningfully less when 25 gauge 
Whitacre (3.3%) is used compared to cutting bevelled 25 gauge 
Quincke needle (10.8%). 
· It was mild in 6%,moderate in 12% and severe in 6% in 
Whitacre group. 
· It was mild in 29%,moderate in 35% and severe in 12% in 
Quincke group. 
· No difference in the number of attempts for successful blockade 
and number of failed blocks. 
· The difference is true and significant with a p value of 0.005 
  
CONCLUSION	
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CONCLUSION 
We conclude that there is real advantage by using pencil-point 25G 
Whiteacrespinal needles in comparison to Cutting bevelled 25G Quincke 
spinal needle in terms of reducing incidence and severity of PDPH. 
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ANNEXURES	
PATIENT  CONSENT  FORM 
Study title  :         
 “A Prospective,    randomized study   comparing the incidence of  
POSTDURAL PUNCTURE HEADACHE following spinal anaesthesia 
in obstetric patients using 25 gauge Whitacre spinal needle and Quincke 
spinal needle. 
Study center :   
Institute of Social Obstetrics, 
Kasthurba Gandhi General Hospital For Women And Children, 
Triplicane, Chennai-5. 
Participant name :          Age:                         Sex : FEMALE                                
I.P. NO 
I confirm that I have understood the purpose of procedure for the 
above study . I have the opportunity to ask the question and all my 
questions and doubts have been answered to my satisfaction. 
I have been explained about the pitfall in the procedure.  I have 
been explained about the safety, advantage and disadvantage of the 
technique. 
 
I understand that my participation in the study is voluntary and that 
I am free to withdraw at anytime without giving any reason. 
I understand that investigator ,regulatory authorities and the ethics 
committee will not need my permission to look at my health records both 
in respect to current study and any further research that may be conducted 
in relation to it, even if I withdraw from the study . I understand that my 
identity will not be revealed in any information released to third parties or 
published , unless as required under the law . I agree not to restrict the use 
of any data or results that arise from the study . 
Time:          
 
Date:                                                             Signature / thumb impression  
 
Place:                                                                           Patient name: 
 
Signature of the investigator: 
 
Name of the investigator: 
PROFORMA 
NAME :     AGE   :                     
SEX   :  FEMALE   WEIGHT :                                         
HEIGHT :    GESTATION: 
INDICATION : 
PREOP  :                                                                                
PRELOADING : 
MONITORS    : 
TIME PR NIBP SPO2 IVF 
     
     
     
     
     
     
     
     
     
     
     
     
 
H/O HEADACHE DAY 1 DAY 2 DAY 3 
ONSET    
CHARACTER    
SITE    
DURATION    
AGGREVATING    
RELIEVING    
OTHERS    
 
TREATMENT: 
 
 
NUMBER OF ATTEMPTS : 
FAILED SPINAL BLOCK : 
DURATION OF SURGERY : 
 
S 
NO IP NO AGE HEIGHT WEIGHT G.AGE
DAY 1 
PDPH
DAY 2 
PDPH
DAY 3 
PDPH
Severity of 
PDPH ATTEMPTS FAILED NAUSEA VOMITING OTHERS
1 4636 25 155 66 37.04 0 0 0 0 1 0 0 0 0
2 4667 23 162 64 40 0 0 0 0 1 0 0 0 0
3 4882 28 158 69 37.7 0 0 0 0 1 0 0 0 0
4 4895 24 158 60 37.9 0 0 0 0 1 0 0 0 0
5 5136 28 158 65 38.3 0 0 0 0 1 0 0 0 0
6 5155 24 150 68 40 0 0 0 0 2 0 0 0 0
7 5157 22 154 65 38 0 0 0 0 1 0 0 0 0
8 5176 25 155 70 38.3 0 0 0 0 1 0 0 0 0
9 5178 23 160 72 37 0 0 0 0 1 0 0 0 0
10 5206 22 158 68 38 0 0 0 0 1 0 0 0 0
11 5222 24 150 67 37 0 0 0 0 1 0 0 0 0
12 5240 30 155 65 37.3 0 0 0 0 1 0 0 0 0
13 5253 25 159 66 37.03 0 0 0 0 1 0 0 0 0
14 5254 23 159 55 38.06 0 0 0 0 2 0 0 0 0
15 5257 25 155 65 37.6 0 0 0 0 1 0 0 0 0
16 5298 23 160 62 37.03 0 0 0 0 1 0 0 0 0
17 5306 27 155 68 40 0 0 0 0 1 0 0 0 0
18 5329 33 144 70 38 0 0 0 0 1 0 0 0 0
19 5340 27 153 65 37.7 0 0 0 0 3 0 0 0 0
20 5415 23 156 65 37 0 0 0 0 1 0 0 0 0
25 GAUGE WHITACRE SPINAL NEEDLE GROUP
S 
NO IP NO AGE HEIGHT WEIGHT G.AGE
DAY 1 
PDPH
DAY 2 
PDPH
DAY 3 
PDPH
Severity of 
PDPH ATTEMPTS FAILED NAUSEA VOMITING OTHERS
21 5421 25 154 62 38 0 0 0 0 1 0 0 0 0
22 5422 26 154 49 37.4 0 0 0 0 2 0 0 0 0
23 5465 25 160 62 38.06 0 0 0 0 1 0 0 0 0
24 5520 25 148 50 37.6 0 0 0 0 1 0 0 0 0
25 5528 28 151 68 38.4 0 0 0 0 2 0 0 0 0
26 5560 26 158 58 37.3 0 0 0 0 1 0 0 0 0
27 5641 25 153 54 39 0 0 0 0 1 0 0 0 0
28 5648 26 156 69 37.03 0 0 0 0 1 0 0 0 0
29 5657 28 151 60 38 0 0 0 0 1 0 0 0 0
30 5677 23 154 70 38.3 0 0 0 0 1 0 0 0 0
31 5698 26 146 50 37.04 0 0 0 0 1 0 0 0 0
32 5699 25 147 50 37.7 0 0 0 0 1 0 0 0 0
33 5711 31 149 52 38 0 0 0 0 1 0 0 0 0
34 5732 22 151 60 38 0 0 0 0 1 0 0 0 0
35 5774 26 152 60 37.4 0 0 0 0 1 0 0 0 0
36 5836 28 158 76 38.4 0 0 0 0 1 0 0 0 0
37 5882 22 156 60 37 0 0 0 0 1 0 0 0 0
38 5891 23 156 60 38.3 0 0 0 0 1 1 0 0 0
39 5895 20 156 65 37.03 0 0 0 0 1 0 0 0 0
40 5898 23 158 67 38 0 0 0 0 1 0 0 0 0
41 5972 23 145 45 38 0 0 0 0 1 0 0 0 0
S 
NO IP NO AGE HEIGHT WEIGHT G.AGE
DAY 1 
PDPH
DAY 2 
PDPH
DAY 3 
PDPH
Severity of 
PDPH ATTEMPTS FAILED NAUSEA VOMITING OTHERS
42 5990 23 154 55 37.6 0 0 0 0 1 0 0 0 0
43 5992 26 150 60 38 0 0 0 0 1 0 0 0 0
44 5999 30 154 58 37 0 0 0 0 1 0 1 1 0
45 6051 23 155 65 38 0 0 0 0 1 0 0 0 0
46 6074 22 160 60 37 0 0 0 0 1 0 0 0 0
47 6332 28 158 62 38.07 0 0 0 0 1 0 0 0 0
48 6355 24 162 60 38 0 0 0 0 1 0 0 0 0
49 6422 24 148 76 38 0 0 0 0 1 0 0 0 0
50 6470 26 154 63 37.06 0 0 0 0 1 0 0 0 0
51 6518 25 148 69 38 0 0 0 0 1 0 0 0 0
52 6525 24 154 66 38 0 0 0 0 2 0 0 0 0
53 6532 29 153 75 38 0 0 0 0 1 0 0 0 0
54 6589 23 157 56 37 0 0 0 0 1 0 0 0 0
55 6667 24 160 62 37.07 0 0 0 0 1 0 0 0 0
56 6676 28 156 65 38 0 0 0 0 2 0 0 0 0
57 6742 27 154 53 38 0 0 0 0 1 0 0 0 0
58 6743 30 156 85 37.06 0 0 0 0 2 0 0 0 0
59 6756 27 158 62 38 0 0 0 0 1 0 0 0 0
60 6800 28 159 68 38 0 0 0 0 1 0 0 0 0
61 6807 20 159 63 38 0 0 0 0 1 0 0 0 0
62 6842 21 147 58 38 0 0 0 0 1 0 0 0 0
S 
NO IP NO AGE HEIGHT WEIGHT G.AGE
DAY 1 
PDPH
DAY 2 
PDPH
DAY 3 
PDPH
Severity of 
PDPH ATTEMPTS FAILED NAUSEA VOMITING OTHERS
63 6852 20 153 53 38 0 0 0 0 1 0 1 1 0
64 6866 29 153 75 37 0 0 0 0 1 0 0 0 0
65 6883 28 161 64 39 0 0 0 0 1 0 0 0 0
66 6901 28 164 66 38 0 0 0 0 1 0 0 0 0
67 6902 24 155 65 39 0 0 0 0 3 0 0 0 0
68 6906 21 162 74 38.04 0 0 0 0 1 0 0 0 0
69 6921 23 161 80 38 0 0 0 0 1 0 0 0 0
70 6945 21 153 49 40 0 0 0 0 1 0 0 0 0
71 6969 26 153 59 40 0 0 0 0 1 0 0 0 0
72 7025 28 156 60 37.06 0 0 0 0 1 0 0 0 0
73 7029 22 153 59 39 0 0 0 0 1 0 0 0 0
74 7161 28 156 55 37 0 0 0 0 1 0 0 0 0
75 7163 21 158 54 39 0 0 0 0 1 1 0 0 0
76 7247 25 162 66 38 0 0 0 0 1 0 0 0 0
77 7249 31 161 54 39 0 1 0 1 1 0 0 0 0
78 7259 27 149 59 39 0 0 0 0 1 0 0 0 0
79 7310 21 154 77 38 0 0 0 0 1 0 0 0 0
80 7335 24 160 62 38 0 0 0 0 1 0 0 0 0
81 7348 23 159 80 40 0 0 0 0 2 0 0 0 0
82 7349 30 149 56 39 0 0 0 0 1 1 0 0 0
83 7360 21 158 68 38 0 0 0 0 1 0 0 0 0
S 
NO IP NO AGE HEIGHT WEIGHT G.AGE
DAY 1 
PDPH
DAY 2 
PDPH
DAY 3 
PDPH
Severity of 
PDPH ATTEMPTS FAILED NAUSEA VOMITING OTHERS
84 7396 22 153 70 39 0 0 0 0 1 0 0 0 0
85 7397 23 157 58 38.3 0 0 0 0 2 0 0 0 0
86 7399 29 154 70 38 0 0 0 0 1 0 0 0 0
87 7400 30 154 65 40 0 0 0 0 1 0 0 0 0
88 7401 25 157 76 38 0 0 0 0 1 0 0 0 0
89 7405 22 160 65 40 0 0 0 0 1 0 0 0 0
90 7414 23 148 55 38 0 0 0 0 1 0 0 0 0
91 7423 25 159 87 38 0 1 0 1 1 0 0 0 0
92 7431 23 157 50 38 0 0 0 0 1 0 0 0 0
93 7432 24 156 60 38 0 0 0 0 1 0 0 0 0
94 7453 28 154 74 39 0 0 0 0 1 0 0 0 0
95 7569 23 149 58 38 0 0 0 0 1 0 0 0 0
96 7588 22 162 70 38 0 0 0 0 1 0 0 0 0
97 7606 32 150 58 38.07 0 0 0 0 1 0 0 0 0
98 7621 22 158 65 39 0 1 0 2 1 0 0 0 0
99 7629 24 155 60 38 0 0 0 0 1 0 0 0 0
100 7687 21 157 76 38 0 0 0 0 1 0 0 0 0
101 7818 29 155 76 40 0 0 0 0 1 0 0 0 0
102 7822 26 150 64 39 0 0 0 0 1 0 0 0 0
103 7965 30 160 63 38 0 0 0 0 1 0 0 0 0
104 8008 23 159 60 40 0 0 0 0 1 0 0 0 0
S 
NO IP NO AGE HEIGHT WEIGHT G.AGE
DAY 1 
PDPH
DAY 2 
PDPH
DAY 3 
PDPH
Severity of 
PDPH ATTEMPTS FAILED NAUSEA VOMITING OTHERS
105 8070 27 156 70 38 0 0 0 0 1 0 0 0 0
106 8084 30 159 64 39 0 0 0 0 1 0 0 0 0
107 8097 25 159 66 38 0 0 0 0 1 0 0 0 0
108 8104 24 162 65 39 0 0 0 0 1 0 0 0 0
109 8110 24 160 68 38 0 0 0 0 1 0 0 0 0
110 8115 22 161 65 38 0 0 0 0 1 0 0 0 0
111 8147 27 155 68 39 0 0 1 3 1 0 0 0 0
112 8181 23 154 65 39 0 0 0 0 1 0 0 0 0
113 8183 25 153 66 38 0 0 0 0 1 0 0 0 0
114 8199 25 155 59 39 0 0 0 0 1 0 0 0 0
115 8204 24 154 62 39 0 0 0 0 1 0 0 0 0
116 8221 26 158 64 39 0 0 0 0 1 0 0 0 0
117 8301 24 158 65 38 0 0 0 0 1 0 0 0 0
118 8304 22 159 64 40 0 0 0 0 1 0 0 0 0
119 8305 20 153 64 40 0 0 0 0 1 0 0 0 0
120 8316 24 159 70 39 0 0 0 0 1 0 0 0 0
S. No. IP NO AGE HEIGHT WEIGHT G.AGE DAY 1 PDPH
DAY 2 
PDPH
DAY 3 
PDPH
Severity of 
PDPH ATTEMPTS FAILED NAUSEA VOMITING OTHERS
1 5860 26 154 60 39 0 0 0 0 1 0 0 0 0
2 5947 22 150 57 38 0 0 0 0 1 0 0 0 0
3 5974 22 154 62 38 0 0 0 0 1 0 0 0 0
4 5987 26 150 64 38.3 0 0 0 0 1 0 0 0 0
5 6229 28 159 68 38 0 0 0 0 2 0 0 0 0
6 6249 26 155 65 40 0 0 0 0 1 0 0 0 0
7 6348 24 158 60 38.4 0 0 0 0 1 0 0 0 0
8 6349 31 154 75 39 0 0 0 0 1 0 0 0 0
9 6351 23 162 66 37 0 0 0 0 1 0 0 0 0
10 6355 25 156 64 38.3 0 0 0 0 2 0 0 0 0
11 6363 26 164 67 38.3 0 0 0 0 1 0 0 0 0
12 6495 28 157 80 38 0 0 0 0 1 0 0 0 0
13 6522 22 152 62 38 0 0 0 0 1 0 0 0 0
14 6524 20 152 55 40 0 0 0 0 1 0 0 0 0
15 6525 24 154 66 39 0 0 0 0 1 0 0 0 0
16 6575 20 156 68 37 0 0 0 0 1 0 0 0 0
17 6609 27 159 75 38 0 0 0 0 1 0 0 0 0
18 6629 27 160 74 39 0 0 0 0 1 0 0 0 0
19 6631 23 162 60 38 0 0 0 0 1 0 0 0 0
20 6634 31 154 75 38.4 0 0 0 0 1 0 0 0 0
25 GAUGE QUINCKE SPINAL NEEDLE GROUP
S. No. IP NO AGE HEIGHT WEIGHT G.AGE DAY 1 PDPH
DAY 2 
PDPH
DAY 3 
PDPH
Severity of 
PDPH ATTEMPTS FAILED NAUSEA VOMITING OTHERS
21 6640 27 154 70 38 0 0 1 1 1 0 0 0 0
22 6644 22 150 67 39 0 0 0 0 1 0 0 0 0
23 6672 23 149 56 39 0 0 0 0 2 0 0 0 0
24 6673 25 152 73 39 0 0 0 0 1 0 0 0 0
25 6682 27 154 54 40 0 0 0 0 1 0 0 0 0
26 6684 24 158 62 39.4 0 0 0 0 1 0 0 0 0
27 6703 24 159 60 39 0 0 0 0 1 0 0 0 0
28 6712 31 158 60 40 0 0 0 0 1 0 0 0 0
29 6728 26 157 60 38.3 0 0 0 0 1 0 0 0 0
30 6731 20 156 63 39 0 0 1 2 1 0 0 0 0
31 6734 21 158 67 39 0 0 0 0 1 0 0 0 0
32 6742 22 155 65 38.3 0 0 0 0 1 0 0 0 0
33 6744 25 157 57 38 0 0 0 0 1 0 0 0 0
34 6745 20 155 52 38 0 0 0 0 1 0 0 0 0
35 6749 30 157 52 38.7 0 0 0 0 1 0 0 0 0
36 6757 32 157 73 39 0 0 0 0 2 0 0 0 0
37 6790 25 159 65 39 0 0 0 0 1 0 0 0 0
38 6808 22 160 70 39 0 0 0 0 2 0 0 0 0
39 6813 28 158 76 39 0 0 0 0 1 0 0 0 0
40 6825 26 159 70 38 0 0 0 0 1 0 0 0 0
41 6852 24 158 64 37.4 0 1 0 1 2 0 0 0 0
S. No. IP NO AGE HEIGHT WEIGHT G.AGE DAY 1 PDPH
DAY 2 
PDPH
DAY 3 
PDPH
Severity of 
PDPH ATTEMPTS FAILED NAUSEA VOMITING OTHERS
42 6860 25 160 69 39 0 0 0 0 1 0 0 0 0
43 6885 21 156 62 38 0 0 0 0 2 0 0 0 0
44 6896 25 152 64 38 0 0 0 0 1 0 0 0 0
45 6977 27 149 55 37.9 0 0 0 0 1 0 0 0 0
46 7000 27 160 65 39.3 0 0 0 0 1 0 0 0 0
47 7024 24 161 55 38.7 0 0 0 0 1 0 0 0 0
48 7027 26 153 59 39 0 0 0 0 1 0 0 0 0
49 7032 24 154 60 39 0 0 0 0 1 0 0 0 0
50 7045 28 159 62 38.6 0 0 0 0 2 0 0 0 0
51 7048 24 152 69 40 0 0 0 0 1 0 0 0 0
52 7059 24 154 70 40 0 0 0 0 1 0 0 0 0
53 7107 23 161 65 38 0 0 0 0 1 0 0 0 0
54 7135 25 158 61 38 0 0 0 0 1 0 0 0 0
55 7140 24 154 65 37.6 0 0 0 0 1 0 0 0 0
56 7146 29 157 64 38 0 0 0 0 1 0 0 0 0
57 7149 24 159 65 39 0 0 0 0 1 0 0 0 0
58 7165 31 155 72 40 0 0 0 0 1 0 0 0 0
59 7201 29 154 60 38.3 0 0 0 0 1 0 0 0 0
60 7219 24 159 68 39 0 0 0 0 2 0 0 0 0
61 7241 27 155 56 40 0 0 0 0 1 0 0 0 0
62 7259 27 152 64 39 0 0 0 0 1 0 0 0 0
S. No. IP NO AGE HEIGHT WEIGHT G.AGE DAY 1 PDPH
DAY 2 
PDPH
DAY 3 
PDPH
Severity of 
PDPH ATTEMPTS FAILED NAUSEA VOMITING OTHERS
63 7303 24 150 66 39 0 0 0 0 1 0 0 0 0
64 7340 29 158 60 38 0 0 0 0 1 0 0 0 0
65 7394 29 150 75 39 0 0 0 0 2 0 0 0 0
66 7402 22 158 63 38 0 0 0 0 2 0 0 0 0
67 7470 28 158 62 38 0 1 0 2 1 0 0 0 0
68 7535 25 157 60 40 0 0 0 0 1 0 0 0 0
69 7559 25 158 55 40 0 0 0 0 1 0 0 0 0
70 7611 20 158 52 37.4 0 0 0 0 1 0 0 0 0
71 7627 28 166 70 375d 0 0 0 0 1 0 0 0 0
72 7662 21 148 50 39 0 0 0 0 1 0 0 0 0
73 7704 25 145 55 38.7 0 0 0 0 1 1 0 0 0
74 7823 22 142 59 38 0 0 0 0 1 0 0 0 0
75 7872 28 155 76 39 0 0 0 0 1 0 0 0 0
76 7927 23 152 53 39 0 0 0 0 1 0 0 0 0
77 8075 20 160 68 37.3 0 1 0 1 1 0 0 0 0
78 8101 26 158 60 39 0 0 0 0 1 0 0 0 0
79 8116 27 145 57 38.4 0 0 0 0 1 0 0 0 0
80 8122 22 159 67 38 0 0 0 0 1 0 0 0 0
81 8149 20 156 56 39 0 0 0 0 1 0 0 0 0
82 8156 23 161 56 37.4 0 1 0 1 1 0 0 0 0
83 8220 31 154 53 39 0 0 0 0 1 0 0 0 0
S. No. IP NO AGE HEIGHT WEIGHT G.AGE DAY 1 PDPH
DAY 2 
PDPH
DAY 3 
PDPH
Severity of 
PDPH ATTEMPTS FAILED NAUSEA VOMITING OTHERS
84 8245 22 161 53 38 0 0 0 0 1 0 0 0 0
85 8268 27 157 69 38 0 0 0 0 1 0 0 0 0
86 8288 31 156 56 39 0 0 0 0 1 0 0 0 0
87 8297 26 156 56 40 0 0 0 0 1 0 0 0 0
88 8299 28 150 60 38 0 0 0 0 1 0 0 0 0
89 8353 30 149 59 37.4 0 0 0 0 1 0 0 0 0
90 8367 22 153 60 38 0 1 0 2 1 0 0 0 0
91 8380 23 148 60 40 0 1 0 2 1 0 0 0 0
92 8412 20 155 59 38.4 0 0 0 0 1 0 0 0 0
93 8437 23 158 74 38 0 0 0 0 1 0 0 0 0
94 8475 29 162 65 39.1 0 0 0 0 1 0 0 0 0
95 8565 24 160 66 38 0 1 0 3 1 0 0 0 0
96 8602 32 157 62 38 0 0 0 0 1 0 0 0 0
97 8612 23 158 74 39.3 0 1 0 2 1 0 0 0 0
98 8641 24 152 57 38.6 0 0 0 0 1 0 0 0 0
99 8645 24 155 65 38.4 0 0 0 0 1 0 0 0 0
S. No. IP NO AGE HEIGHT WEIGHT G.AGE DAY 1 PDPH
DAY 2 
PDPH
DAY 3 
PDPH
Severity of 
PDPH ATTEMPTS FAILED NAUSEA VOMITING OTHERS
100 8652 26 155 57 39.3 0 0 0 0 1 0 0 0 0
101 8662 24 162 82 38 0 0 0 0 1 0 0 0 0
102 8668 25 157 65 38.3 0 1 0 3 1 0 0 0 0
103 8675 21 153 75 38 0 0 0 0 1 0 0 0 0
104 8699 24 156 70 40 0 0 0 0 1 0 0 0 0
105 8706 20 151 60 38.4 0 0 0 0 1 0 0 0 0
106 8723 23 160 76 38 0 0 0 0 1 0 0 0 0
107 8728 21 155 73 39 0 0 0 0 1 0 0 0 0
108 8736 23 151 55 38.3 0 0 0 0 1 0 0 0 0
109 8754 26 156 65 40 0 0 0 0 1 0 0 0 0
110 8769 23 154 55 39 0 0 1 2 1 0 0 0 0
111 8775 26 152 65 39 0 0 0 0 1 0 0 0 0
112 8777 25 153 58 40 0 0 0 0 1 0 0 0 0
113 8778 20 154 64 39 0 0 0 0 1 0 0 0 0
114 8796 22 158 64 38 0 0 0 0 1 0 0 0 0
115 8818 28 156 68 38.7 0 0 0 0 1 0 0 0 0
116 8824 25 158 59 40 0 0 1 2 1 0 0 0 0
117 8826 22 159 65 38 0 0 0 0 1 0 0 0 0
118 8833 28 158 62 38 0 0 0 0 1 0 0 0 0
119 8862 30 157 63 39 0 0 0 0 1 0 0 0 0
120 8899 33 159 64 39 0 0 0 0 1 0 0 0 0
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